Comments? Send me a text message.
GLP-1 Drugs, like Ozempic and Wegovy, originally developed to treat diabetes, have been found to lower risk-factors for a broad-range of conditions that accelerate the aging process. But there are also risk factors that need to be taken into account.
The benefits of GLP-1 drugs include reduced risk of seizures, heart attack, stroke, other cardiovascular concerns, suicide ideation, self-harm, bulimia and psychotic disorders. They decrease inflammation in the brain and reduce the risk of neurocognitive disorders such as dementia, Alzheimer's and Parkinson's.
The risks include gastrointesinal problems such as nausea, vomiting and diarrhea. More concerning, there are rare cases of "paralysis of the stomach," and new information that GLP-1 drugs can have serious adverse effects on the pancreas and kidneys.
If you plan to use GLP-1 drugs, do so with medical supervision and continue to monitor for signs of pancreatitis and abnormal kidney function.
If you want to support this work, click above, subscribe to the MINDRAMP Podcast, or sign up for the free Flourish As You Age newsletter for reviews of current research, reflections, updates, and special extras from my book-in-progress